
|Articles|August 10, 2017
ARG Forms Rare Disease Advisory Board
Advertisement
Atlantic Research Group, Inc. (ARG)-a rare disease-focused contract research organization (CRO)-announced that it formed its rare disease strategic advisory board (SAB). The SAB will consist of outside scientific experts, patient advocates, and former executives from rare disease-focused biotechs.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5



